1. Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomised, controlled, open-label, blinded endpoint phase 3 trial. Issue 10175 (9th March 2019) Authors: Hanley, Daniel F; Thompson, Richard E; Rosenblum, Michael; Yenokyan, Gayane; Lane, Karen; McBee, Nichol; Mayo, Steven W; Bistran-Hall, Amanda J; Gandhi, Dheeraj; Mould, W Andrew; Ullman, Natalie; Ali, Hasan; Carhuapoma, J Ricardo; Kase, Carlos S; Lees, Kennedy R; Dawson, Jesse; Wilson, Alastair; ... Journal: Lancet Issue: Volume 393:Issue 10175(2019) Page Start: 1021 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Surgical Performance Determines Functional Outcome Benefit in the Minimally Invasive Surgery Plus Recombinant Tissue Plasminogen Activator for Intracerebral Hemorrhage Evacuation (MISTIE) Procedure. Issue 6 (1st June 2019) Authors: Awad, Issam A; Polster, Sean P; Carrión-Penagos, Julián; Thompson, Richard E; Cao, Ying; Stadnik, Agnieszka; Money, Patricia Lynn; Fam, Maged D; Koskimäki, Janne; Girard, Romuald; Lane, Karen; McBee, Nichol; Ziai, Wendy; Hao, Yi; Dodd, Robert; Carlson, Andrew P; Camarata, Paul J; Caron, Jean-Loui... Journal: Neurosurgery Issue: Volume 84:Issue 6(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗